Latest Blogs

Jan 21, 2022
Dr. Lewis E. Foxhall and Zuzanna Tittenbrun describe the International Cancer Control Partnership and ASCO's role as a member of this international collaborative.
Jan 20, 2022
What do we mean when we say that equity, diversity, and inclusion is not one thing, it’s everything?
Jan 06, 2022
Dr. Leslie M. Randall, Dr. Mark Stoler, and I explore the decline in cervical cancer incidence which has not corresponded to a decline in deaths from high-risk invasive disease. 
Dec 17, 2021
Dr. Anghel Adrian Udrea began his career in Romania at a time when professional opportunities were limited, and he has spent 3 decades working to make a difference for the next generation of Romanian oncologists.
Subscribe to this column

Edward Paul Balaban, DO, FACP, FASCO

Edward P. Balaban, DO, FACP, FASCO, is the medical director for the Cancer Care Partnership with Penn State University Cancer Institute and professor of medicine at Penn State Hershey Cancer Institute. He has served as a Practice Guideline Implementation Network (PGIN) representative for Weight-Based Dosing Chemotherapy for Cancer Patients and Gastrointestinal Guideline Advisory Groups. Dr. Balaban is past president of the Pennsylvania Society of Oncology and Hematology. He serves as an ASCO delegate to the American Medical Association House of Delegates (AMA HOD).

Disclosure.

Dec 02, 2021
The AMA House of Delegates adopted a resolution to remain committed with increased efforts against the resumption of the sequestration payment applied to all Medicare fee-for-service claims.
Jun 30, 2021
ASCO’s delegation to the American Medical Association (AMA) recently met virtually with the AMA’s House of Delegates (HOD), with a focus on payment reform models. 
Dec 02, 2020
Despite the virtual nature of the AMA House of Delegates meeting, the decisions made there have a very real impact on our profession and the patients we serve.
Jun 10, 2020
Although our societal meetings, including the AMA House of Delegates meeting, are shortened, they have never been more important than they are at this moment.
Dec 03, 2019
ASCO's delegation to the AMA HOD invites all ASCO members to share their thoughts and concerns concerning issues affecting the practice of oncology, as your input directly impacts the delegation's work.
Jun 20, 2019
Key cancer-related topics discussed at the AMA-HOD meeting included alcohol ingestion as a causation risk factor, appropriate guidelines for opioids in the cancer setting, and the use of de-identified patient information.

Pages